Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 10, 2025 09:50 ET | Source: Research and Markets

Epithelioma Treatment Market Forecast and Company Analysis Report 2025-2034: Amgen, AstraZeneca, BeiGene, BMS, F. Hoffmann-La Roche, J&J, Merck, Novartis, Pfizer, Regeneron, Sanofi, Sun Pharma

Dublin, April 10, 2025 (GLOBE NEWSWIRE) -- The "Epithelioma Treatment Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034" report has been added to ...
January 29, 2024 05:03 ET | Source: Research and Markets

Nasopharyngeal Cancer Market Set for Exceptional Growth: Forecast Analysis 2024-2034 with Focus on Chemotherapy and Asia-Pacific Region

Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "Global Nasopharyngeal Cancer Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's offering.In the recent...
January 24, 2023 09:18 ET | Source: Research and Markets

World Hepatocellular Carcinoma Treatment Market Analysis Report 2022-2027: Increasing Adoption for Biological Therapies & Anticipated Launch of Emerging Drugs Bodes Well for the Market

Dublin, Jan. 24, 2023 (GLOBE NEWSWIRE) -- The "Hepatocellular Carcinoma Treatment Market Forecast- Epidemiology & Pipeline Analysis 2022-2027" report has been added to ResearchAndMarkets.com's...
September 21, 2022 07:53 ET | Source: Research and Markets

Global PD-1/PDL-1 Inhibitor Market Report 2022: Increase in PD-1/PDL-1 Inhibitor Based Combination Regimens Fueling Sector

Dublin, Sept. 21, 2022 (GLOBE NEWSWIRE) -- The "PD-1/PDL-1 Inhibitor Market - A Global and Regional Analysis: Focus on Epidemiology, Product, and Region - Analysis and Forecast, 2022-2032" report...
March 08, 2021 07:33 ET | Source: Research and Markets

Global Hepatocellular Carcinoma Treatment Market 2021-2025: Market Sizing, Market Forecast and Key Vendor Profiles

Dublin, March 08, 2021 (GLOBE NEWSWIRE) -- The "Global Hepatocellular Carcinoma Treatment Market 2021-2025" report has been added to ResearchAndMarkets.com's offering. The hepatocellular carcinoma...